Citation Impact
Citing Papers
Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
2010
Evolution of the Cancer Stem Cell Model
2014 Standout
Genetics of adult glioma
2012
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma
2009
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
2017 Standout
Phase I Trial of Single-Dose Temozolomide and Continuous Administration of O6-Benzylguanine in Children with Brain Tumors: a Pediatric Brain Tumor Consortium Report
2007
Transfection of pseudouridine-modified mRNA encoding CPD-photolyase leads to repair of DNA damage in human keratinocytes: A new approach with future therapeutic potential
2013 StandoutNobel
Epigenetics as a mechanism driving polygenic clinical drug resistance
2006
Glioblastoma and Other Malignant Gliomas
2013 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Identifying DNA Methylation Biomarkers of Cancer Drug Response
2005
Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial
2011
MGMT methylation: A marker of response to temozolomide in low‐grade gliomas
2006
Genetic alterations and signaling pathways in the evolution of gliomas
2009
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma
2008
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies
2009
Cancer epigenetics reaches mainstream oncology
2011
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Malignant Gliomas in Adults
2008 Standout
MGMT Promoter Methylation and Glioblastoma Prognosis: A Systematic Review and Meta-analysis
2013
DNA Repair in Mammalian Cells
2009
Non-coding RNAs in human disease
2011 Standout
Management of brain metastases
2004
Anti‐O6‐Methylguanine‐Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker*
2008
Primary brain tumours in adults
2012 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
2006 Standout
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
2019 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)
2006
Epigenetic modifications and human disease
2010 Standout
Cancer epigenomics: DNA methylomes and histone-modification maps
2007 Standout
Promoter Methylation and Polymorphisms of the<i> MGMT</i> Gene in Glioblastomas: A Population-Based Study
2008
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Management of glioblastoma: State of the art and future directions
2020 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
2018 Standout
Correlations Between O6-Methylguanine DNA Methyltransferase Promoter Methylation Status, 1p and 19q Deletions, and Response to Temozolomide in Anaplastic and Recurrent Oligodendroglioma: A Prospective GICNO Study
2006
Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
2008 StandoutNobel
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
The epidemiology of glioma in adults: a "state of the science" review
2014 Standout
ABERRANT DNA METHYLATION AS A CANCER-INDUCING MECHANISM
2005
Maintenance Therapy to Suppress Micrometastasis: The New Challenge for Adjuvant Cancer Treatment
2005
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
2021 Standout
An imaging-based approach predicts clinical outcomes in prostate cancer through a novel support vector machine classification
2016
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
Quantitative analysis of O6-alkylguanine-DNA alkyltransferase in malignant glioma
2006
Methylation of O6-Methylguanine DNA Methyltransferase and Loss of Heterozygosity on 19q and/or 17p Are Overlapping Features of Secondary Glioblastomas with Prolonged Survival
2007
Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
2008
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Works of L. Arribas being referenced
Breast-Conservative Surgery With Close or Positive Margins: Can the Breast Be Preserved With High-Dose-Rate Brachytherapy Boost?
2007
Concomitant and adjuvant temozolomide (TMZ) and whole brain irradiation (WBI) on patients affected with brain metastases (BM): a randomized multicentric phase II trial
2003
CpG Island Hypermethylation of the DNA Repair Enzyme Methyltransferase Predicts Response to Temozolomide in Primary Gliomas
2004
Support vector machine classification of brain metastasis and radiation necrosis based on texture analysis in MRI
2015